Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Neely] All right, we're gonna do another one. - [Jaye] The needles will deliver immunoglobulin therapy, which will block antibodies that attack Freeman's body. - [Neely] Good job. - [Jaye] It was ...

These foci are commonly in the superior pulmonary veins; this is an important factor in the electrophysiologic ... with AF — in the absence of AV-blocking drugs— is 150 ± 20 bpm.

Factor FVII and Factor X, and had no impact on coagulation cascade. SYS6051-mAb could quickly enter cells through endocytosis 3 hours after treatment, faster than the antibody of the MTI-ADC.

We will address these points by: - including SHP-1 inhibitors in the DuoHexaBody-CD37 cytotoxicity experiments to address the role of SHP-1 - investigating which Fc receptors are involved in the ...